Spyre Therapeutics CEO Turtle Cameron Sells 15,000 Shares

Spyre Therapeutics, Inc. (SYRE) has recently disclosed that its Director and Chief Executive Officer, Cameron, has executed two separate transactions involving the sale of company shares. Firstly, Cameron sold 957 shares at a price of $31.82 per share on February 2, 2026. Subsequently, on the same day, Cameron sold an additional 14,043 shares at a price of $32.87 per share.